omkar-pharmachem-ltd

Home

Omkar Pharmachem Ltd

Omkar Pharmachem Ltd Financials

Omkar Pharmachem Ltd Financial Statement

Omkar Pharmachem Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	0.14	0.14	0.14
Operating Expense	0.05	0.09	0.06
Net Profit	0.09	0.05	-0.02
Net Profit Margin	64.29	35.71	-14.29
Earning Per Share	0.09	0.05	-0.02
EBIDTA	0.09	0.05	0.07
Effective Tax Rate	TBA	TBA	75

Particulars	Sep 2024
Revenue	0.14
Operating Expense	0.05
Net Profit	0.09
Net Profit Margin	64.29
Earning Per Share	0.09
EBIDTA	0.09
Effective Tax Rate	TBA

Omkar Pharmachem Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	0.54	0.54	0.54
Operating Expenses Annual	0.26	0.23	0.27
Operating Profit Annual	0.29	0.31	0.27
Interest Annual	0.03	0.05	0.06
Depreciation	0.00	0.00	0.00
Net Profit Annual	0.19	0.20	0.18
Tax Annual	0.06	0.07	0.03

Particulars	Mar 2024
Total Revenue Annual	0.54
Operating Expenses Annual	0.26
Operating Profit Annual	0.29
Interest Annual	0.03
Depreciation	0.00
Net Profit Annual	0.19
Tax Annual	0.06

Omkar Pharmachem Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.13	0.21	0.04
Cash Flow from Operations	0.30	0.28	0.20
Cash Flow from Investing	-0.01	TBA	-0.01
Cash Flow from Financing	-0.35	-0.35	-0.03
Cash Flow at the End	0.07	0.13	0.21

Particulars	Mar 2024
Cash Flow at the Beginning	0.13
Cash Flow from Operations	0.30
Cash Flow from Investing	-0.01
Cash Flow from Financing	-0.35
Cash Flow at the End	0.07

Omkar Pharmachem Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	53.70	59.26	50
PBIT Margin (%)	53.70	59.26	50
PBT Margin (%)	-1,674.08	-1,125.93	-783.33
Net PROFIT Margin (%)	35.19	37.04	33.33
Return On Networth / Equity (%)	1.88	1.98	1.79
Return On Networth /Employed (%)	2.66	2.95	2.46
Return On Assets (%)	2.11	2.22	2.00
Total Debt / Equity (X)	0.05	0.09	0.10
Asset Turnover Ratio (%)	0.06	0.06	0.06

Particulars	Mar 2024
PBDIT Margin (%)	53.70
PBIT Margin (%)	53.70
PBT Margin (%)	-1,674.08
Net PROFIT Margin (%)	35.19
Return On Networth / Equity (%)	1.88
Return On Networth /Employed (%)	2.66
Return On Assets (%)	2.11
Total Debt / Equity (X)	0.05
Asset Turnover Ratio (%)	0.06

Omkar Pharmachem Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.01	0.00	0.01
Total Current Assets Annual	0.18	0.26	0.29
Non Current Assets Annual	9.41	9.47	9.54
Total Shareholders Funds Annual	9.23	9.04	8.85
Total Assets Annual	9.59	9.73	9.83

Particulars	Mar 2024
Fixed Assets Annual	0.01
Total Current Assets Annual	0.18
Non Current Assets Annual	9.41
Total Shareholders Funds Annual	9.23
Total Assets Annual	9.59

Omkar Pharmachem Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 15, 2024, Omkar Pharmachem Ltd has a market capitalization of 22.67 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Omkar Pharmachem Ltd is debt-free with a debt-to-equity ratio of 0.03.

In FY 2023 , Omkar Pharmachem Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Omkar Pharmachem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and NaN% annually, respectively..

Omkar Pharmachem Ltd's current PE ratio is 119.32.

Omkar Pharmachem Ltd's ROCE averaged 3.0% from the FY ending March 2022 to 2024, with a median of 3.0%. It peaked at 3.2% in March 2023, reflecting strong capital efficiency over the period..

Omkar Pharmachem Ltd's latest EBIT is Rs. 0.28 Cr, surpassing the average EBIT of Rs. 0.29 Cr over the 5 years..